Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06569043 · ClinicalTrials.gov registry record · NA
Appetite Responses to Breakfast Bar Product
A NA study, sponsored by General Mills.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT06569043: Completed NA study, sponsored by General Mills.
NCT06569043 is a NA study that has completed, run by General Mills. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06569043, a NA study, has completed, sponsored by General Mills.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to investigate appetite responses to 2 cereal products in healthy adults.
Primary Outcome
Visual Analogue Scale for "how hungry are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more hunger. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome.
Interventions
- OTHER Breakfast Bar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-10-20 |
| Est. Completion | 2024-10-24 |
| Phase | NA |
What the finished NCT06569043 record still lists
NCT06569043 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Breakfast Bar is the first listed.
NCT06569043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06569043 about?
NCT06569043 is a clinical study titled "Appetite Responses to Breakfast Bar Product". The purpose of this clinical trial is to investigate appetite responses to 2 cereal products in healthy adults.
What is the current status of trial NCT06569043?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2024-10-20. Estimated completion is 2024-10-24.
What interventions are being tested in trial NCT06569043?
The interventions under investigation include: Breakfast Bar (OTHER).
Who is sponsoring clinical trial NCT06569043?
This trial is sponsored by General Mills, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06569043's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI